Navigation Links
CV Therapeutics Reports 2007 Third Quarter Financial Results
Date:11/6/2007

s 1,407 - 6,774 -

Total costs and expenses 53,665 76,312 207,910 232,976

Loss from operations (33,902) (64,110) (147,489) (208,860)

Other income (expense), net:

Interest and other income, net 2,847 4,582 10,112 12,100

Interest expense (3,166) (3,166) (9,498) (9,501)

Total other income (expense), net (319) 1,416 614 2,599

Net loss $(34,221) $(62,694) $(146,875) $(206,261)

Basic and diluted net loss

per share $(0.58) $(1.23) $(2.48) $(4.36)

Shares used in computing basic

and diluted net loss per share 59,458 51,067 59,213 47,340

(1) Costs and expenses include non-recurring stock-based compensation expense related to the acceleration of stock options and the voluntary forfeiture of stock appreciation rights as follows:

Cost of sales $- $- $109 $-

Research and development - - 4,606 -

Selling, general and

administrative - - 8,471 -

Total non-recurring

stock-based compensation

charges $- $- $13,186 $-

Reconciliation of GAAP Items

to Non-GAAP Items (2):

Net loss, as reported $(34,221) $(62,694) $(146,875) $(206,261)

Adjustments:

Non-recurring stock-based

compensation charges - - 13,186 -

Restructuring charges 1,407 - 6,774 -

Net loss, non-GAAP $(32,814) $(62,694) $(126,915) $(206,261)

Basic and diluted net loss

per share, as reported $(0.58) $(1.23) $(2.48) $(4.36)

Adjustments
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Prime Therapeutics Receives TIPPS Certification
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
4. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
7. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
8. Prime Therapeutics Announces URAC Accreditation
9. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
10. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... the first in the world to discover a gene ... jaw. , Ameloblastoma is an odontogenic tumour with a ... often found in the posterior of the lower jaw. ... deficiencies in the jaws as well as loss of ... need for surgery and the recurrence of ameloblastoma, but ...
(Date:4/24/2014)... the first flu pandemic in the 21st century. The ... than 50 people in the country. Since 2011 the ... seasons). , Infections with influenza pH1N1 virus vary ... has recommended Tamiflu for treatment of patients with severe ... that it targets viral proteins which mutate quickly and ...
(Date:4/23/2014)... from Sub-Saharan Africa, Latin America and Caribbean islands ... new research from St. Michael,s Hospital. , The ... of Obstetrics and Gynaecology , assessed the differences ... native-born women in six high-immigration countries Australia ... Valencia) and the United States (California, New Jersey ...
(Date:4/23/2014)... looking to give exercise enthusiasts the extra nudge they ... that a cyber buddy can help. , The study, ... , is the first to indicate that although a ... a software-generated partner also can be effective. , "We ... still motivate people to give greater effort while exercising ...
(Date:4/23/2014)... have identified an important enzyme pathway that helps prevent ... chromosomes, a condition that has been directly linked to ... of biochemistry, found that near the end of cell ... ensures any breaks in DNA are fully repaired before ... daughter cells. This process helps safeguard against some of ...
Breaking Medicine News(10 mins):Health News:Pregnancy complications may be more common in immigrants from certain regions 2Health News:Cyber buddy is better than 'no buddy' 2Health News:Study identifies enzymes that help fix cancer-causing DNA defects 2
... for its complementary therapy. Silymarin, is a mixture made of ... number of active constituents called flavolignans, which protect the liver ... in the treatment of liver conditions like Cirrhosis and ... been suggested that Silymarin may also help control blood sugar ...
... the park; ,Age is grey,a toothless hag // ,Stumbling ... reflect the glory of youth and the dismal emotions that ... they shrink from the thought of greying hair, sagging flesh ... old age. ,With the changing trends, the ...
... of acquiring a sexually transmitted infection, according to the ... November issue of Pediatrics which reports the study suggests ... spreading such infections by up to 50 percent, which ... ,This study is only one of many ...
... is in a dilemma; whether to preserve the Roman ... a relative yes-sometimes //policy that gives us an effective ... on contraception, abortion and infallibility to new challenges," according ... a Catholic newspaper. ,Cardinal Javier Lozano Barragan ...
... health trusts, 300 sexual assault cases have been reported in ... ,During the period November 2003-March 2006, women have been ... England alone. Of these, patients attacked other patients in 224 ... the psychiatric wards have mixed sex. ,Mental health campaigner Marjorie ...
... across Indiana have no one to look out for them. ... homes //or in the community without any money or family ... or another condition that impairs their judgment or ability to ... explode as baby boomers age. ,There is only one ...
Cached Medicine News:Health News:A Wonder Drug From Milk Thistle 2Health News:Botox – The 'Celebrity' Dru 2Health News:Risk of STD Lowered with Circumcision 2Health News:Sexual assault cases in mixed-sex psychiatric wards on the high 2Health News:Hoosiers Live at the Mercy of Nursing Homes 2Health News:Hoosiers Live at the Mercy of Nursing Homes 3
(Date:1/15/2014)... Calif. , Jan. 15, 2014 Massachusetts ... (NASDAQ: AMGN ) announced today that ... discover and validate new therapeutic targets and develop ... chronic disorder that affects millions worldwide. The MGH-Broad-Amgen ...
(Date:1/15/2014)... 2014  In an unprecedented effort to curb the spread of "superbugs" ... transport vehicles, an advanced and portable UV germicidal lamp manufactured by ... time. In order to prevent EMS paramedics and ... West Palm Beach Fire Rescue is the first ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
RapidStrep A test is a qualitative test that detects group A,streptococcal antigen. The test is a rapid, in vitro assay. It is,intended for professional use to help diagnose Strep A,infection i...
The IntraStent DoubleStrut Biliary Stent represents a completely new direction in stent design. The combination of parallel struts and unique cell geometry provide unparalleled performance....
Inquire...
OneStep Midstream Urine hCG Pregnancy InstaTest is a test kit for the determination of hCG(Human Chorionic Gonadotropin) in urine specimens. This test kit is used to obtain a visual, qualitative resu...
Medicine Products: